|
|
| DRD1_PIG |
DRD1 |
D(1A) dopamine receptor |
2.1e-166 |
1.00
|
| DRD4_HUMAN |
DRD4 |
D(4) dopamine receptor |
3.369e-139 |
1.00
|
| 5HT2A_PIG |
HTR2A |
5-hydroxytryptamine receptor 2A |
2.223e-135 |
1.00
|
| DRD3_HUMAN |
DRD3 |
D(3) dopamine receptor |
2.489e-122 |
1.00
|
| DRD2_HUMAN |
DRD2 |
D(2) dopamine receptor |
4.328e-118 |
1.00
|
| 5HT1A_RAT |
Htr1a |
5-hydroxytryptamine receptor 1A |
4.247e-168 |
0.67
|
| ADRB1_PIG |
ADRB1 |
Beta-1 adrenergic receptor |
1.543e-116 |
0.44
|
| Q9TSW7_PIG |
ADRA1A |
Alpha-1A adrenergic receptor |
1.328e-112 |
0.37
|
| GTR3_HUMAN |
SLC2A3 |
Solute carrier family 2, facilitated glucose transporter member 3 |
8.244e-111 |
0.39
|
| 5HT1A_HUMAN |
HTR1A |
5-hydroxytryptamine receptor 1A |
2.655e-103 |
0.55
|
| 5HT7R_HUMAN |
HTR7 |
5-hydroxytryptamine receptor 7 |
1.057e-96 |
0.93
|
| ADA1D_HUMAN |
ADRA1D |
Alpha-1D adrenergic receptor |
1.574e-96 |
0.56
|
| ADA1A_HUMAN |
ADRA1A |
Alpha-1A adrenergic receptor |
7.967e-96 |
0.56
|
| 5HT7R_RAT |
Htr7 |
5-hydroxytryptamine receptor 7 |
1.117e-94 |
0.67
|
| GTR2_HUMAN |
SLC2A2 |
Solute carrier family 2, facilitated glucose transporter member 2 |
3.119e-94 |
0.39
|
| ADA1B_HUMAN |
ADRA1B |
Alpha-1B adrenergic receptor |
6.622e-94 |
0.56
|
| DRD2_RAT |
Drd2 |
D(2) dopamine receptor |
4.697e-86 |
0.61
|
| AP2S1_RAT |
Ap2s1 |
AP-2 complex subunit sigma |
8.467e-73 |
0.39
|
| ADA1A_RABIT |
ADRA1A |
Alpha-1A adrenergic receptor |
3.441e-59 |
0.46
|
| 5HT2A_RAT |
Htr2a |
5-hydroxytryptamine receptor 2A |
3.798e-59 |
0.55
|
| ADA1A_RAT |
Adra1a |
Alpha-1A adrenergic receptor |
3.454e-57 |
0.48
|
| ADA1D_RAT |
Adra1d |
Alpha-1D adrenergic receptor |
3.99e-55 |
0.48
|
| ADA1A_BOVIN |
ADRA1A |
Alpha-1A adrenergic receptor |
3.321e-45 |
0.48
|
| ADA1B_RAT |
Adra1b |
Alpha-1B adrenergic receptor |
3.442e-44 |
0.47
|
| DRD1_BOVIN |
DRD1 |
D(1A) dopamine receptor |
3.977e-42 |
0.47
|
| TAAR5_MOUSE |
Taar5 |
Trace amine-associated receptor 5 |
1.119e-38 |
0.48
|
| Q5YLN7_CANLF |
SCN5A |
Voltage-gated sodium channel Nav1.5 cardiac isoform |
3.56e-37 |
0.29
|
| 5HT7R_CAVPO |
HTR7 |
5-hydroxytryptamine receptor 7 |
3.614e-36 |
0.34
|
| DRD1_HUMAN |
DRD1 |
D(1A) dopamine receptor |
2.645e-32 |
0.46
|
| GTR1_HUMAN |
SLC2A1 |
Solute carrier family 2, facilitated glucose transporter member 1 |
1.861e-30 |
0.39
|
| DRD3_RAT |
Drd3 |
D(3) dopamine receptor |
2.728e-30 |
0.46
|
| 5HT2A_HUMAN |
HTR2A |
5-hydroxytryptamine receptor 2A |
6.141e-29 |
0.50
|
| 5HT2A_BOVIN |
HTR2A |
5-hydroxytryptamine receptor 2A |
7.154e-28 |
0.40
|
| 5HT1B_RAT |
Htr1b |
5-hydroxytryptamine receptor 1B |
9.374e-28 |
0.55
|
| 5HT1D_MOUSE |
Htr1d |
5-hydroxytryptamine receptor 1D |
3.348e-27 |
0.35
|
| ADA2A_RAT |
Adra2a |
Alpha-2A adrenergic receptor |
3.349e-26 |
0.43
|
| ACES_MOUSE |
Ache |
Acetylcholinesterase |
4.094e-25 |
0.37
|
| AL3A1_HUMAN |
ALDH3A1 |
Aldehyde dehydrogenase, dimeric NADP-preferring |
2.211e-22 |
0.33
|
| DRD3_CHLAE |
DRD3 |
D(3) dopamine receptor |
2.945e-22 |
0.54
|
| PD1L1_HUMAN |
CD274 |
Programmed cell death 1 ligand 1 |
4.773e-22 |
0.33
|
| UR2R_RAT |
Uts2r |
Urotensin-2 receptor |
3.355e-20 |
0.44
|
| NLRP1_HUMAN |
NLRP1 |
NACHT, LRR and PYD domains-containing protein 1 |
4.659e-20 |
0.45
|
| DRD1_RAT |
Drd1 |
D(1A) dopamine receptor |
8.936e-20 |
0.51
|
| MDR1_HUMAN |
ABCB1 |
ATP-dependent translocase ABCB1 |
8.943e-20 |
0.42
|
| ADRB2_CANLF |
ADRB2 |
Beta-2 adrenergic receptor |
1.038e-19 |
0.43
|
| 5HT2B_RAT |
Htr2b |
5-hydroxytryptamine receptor 2B |
3.071e-19 |
0.51
|
| 5HT2C_HUMAN |
HTR2C |
5-hydroxytryptamine receptor 2C |
4.708e-19 |
0.51
|
| EBPL_HUMAN |
EBPL |
Emopamil-binding protein-like |
2.576e-18 |
0.29
|
| ADA2A_HUMAN |
ADRA2A |
Alpha-2A adrenergic receptor |
3.339e-18 |
0.47
|
| ACES_ELEEL |
ache |
Acetylcholinesterase |
4.654e-18 |
0.39
|
| NK3R_HUMAN |
TACR3 |
Neuromedin-K receptor |
1.11e-16 |
0.46
|
| ACES_RAT |
Ache |
Acetylcholinesterase |
2.22e-16 |
0.40
|
| SC6A4_RAT |
Slc6a4 |
Sodium-dependent serotonin transporter |
2.22e-16 |
0.55
|
| DRD2_BOVIN |
DRD2 |
D(2) dopamine receptor |
3.331e-16 |
0.40
|
| SGMR1_HUMAN |
SIGMAR1 |
Sigma non-opioid intracellular receptor 1 |
3.331e-16 |
0.47
|
| NK1R_MOUSE |
Tacr1 |
Substance-P receptor |
9.992e-16 |
0.30
|
| SC6A4_MOUSE |
Slc6a4 |
Sodium-dependent serotonin transporter |
1.332e-15 |
0.31
|
| PLPL6_MOUSE |
Pnpla6 |
Neuropathy target esterase |
1.665e-15 |
0.39
|
| SYFA_STRP8 |
pheS |
Phenylalanine--tRNA ligase alpha subunit |
2.109e-15 |
0.29
|
| 5HT6R_HUMAN |
HTR6 |
5-hydroxytryptamine receptor 6 |
2.887e-15 |
0.47
|
| SGMR1_RAT |
Sigmar1 |
Sigma non-opioid intracellular receptor 1 |
3.442e-15 |
0.46
|
| SGMR1_CAVPO |
SIGMAR1 |
Sigma non-opioid intracellular receptor 1 |
3.775e-15 |
0.39
|
| HRH2_HUMAN |
HRH2 |
Histamine H2 receptor |
5.329e-15 |
0.76
|
| NK3R_RAT |
Tacr3 |
Neuromedin-K receptor |
7.772e-15 |
0.40
|
| PDK4_HUMAN |
PDK4 |
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial |
1.243e-14 |
0.32
|
| NTR1_HUMAN |
NTSR1 |
Neurotensin receptor type 1 |
3.286e-14 |
0.37
|
| ADA2B_HUMAN |
ADRA2B |
Alpha-2B adrenergic receptor |
3.642e-14 |
0.45
|
| DRD2_CHLAE |
DRD2 |
D(2) dopamine receptor |
5.584e-14 |
0.54
|
| EHMT2_HUMAN |
EHMT2 |
Histone-lysine N-methyltransferase EHMT2 |
6.917e-14 |
0.31
|
| FAAH1_HUMAN |
FAAH |
Fatty-acid amide hydrolase 1 |
1.336e-13 |
0.48
|
| CASB_RAT |
Csn2 |
Beta-casein |
2.482e-13 |
0.29
|
| BCL2_MOUSE |
Bcl2 |
Apoptosis regulator Bcl-2 |
3.709e-13 |
0.38
|
| 5HT1D_CAVPO |
HTR1D |
5-hydroxytryptamine receptor 1D |
1.132e-12 |
0.28
|
| CHKA_HUMAN |
CHKA |
Choline kinase alpha |
1.298e-12 |
0.35
|
| 5HT2C_RAT |
Htr2c |
5-hydroxytryptamine receptor 2C |
1.343e-12 |
0.44
|
| NOX5_HUMAN |
NOX5 |
NADPH oxidase 5 |
1.394e-12 |
0.31
|
| CCR8_HUMAN |
CCR8 |
C-C chemokine receptor type 8 |
1.458e-12 |
0.33
|
| 5HT1B_HUMAN |
HTR1B |
5-hydroxytryptamine receptor 1B |
2.299e-12 |
0.45
|
| SL9A1_RAT |
Slc9a1 |
Sodium/hydrogen exchanger 1 |
3.834e-12 |
0.35
|
| B2CL1_HUMAN |
BCL2L1 |
Bcl-2-like protein 1 |
4.477e-12 |
0.41
|
| PRIO_SHEEP |
PRNP |
Major prion protein |
4.678e-12 |
0.29
|
| 5HT1D_HUMAN |
HTR1D |
5-hydroxytryptamine receptor 1D |
6.623e-12 |
0.45
|
| PDK3_HUMAN |
PDK3 |
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial |
6.916e-12 |
0.32
|
| DRD5_HUMAN |
DRD5 |
D(1B) dopamine receptor |
1.805e-11 |
0.47
|
| ADA2C_HUMAN |
ADRA2C |
Alpha-2C adrenergic receptor |
2.339e-11 |
0.47
|
| CASP5_HUMAN |
CASP5 |
Caspase-5 |
6.273e-11 |
0.29
|
| NK1R_HUMAN |
TACR1 |
Substance-P receptor |
6.32e-11 |
0.46
|
| FIBB_HUMAN |
FGB |
Fibrinogen beta chain |
8.878e-11 |
0.29
|
| ADA2B_RAT |
Adra2b |
Alpha-2B adrenergic receptor |
9.343e-11 |
0.47
|
| CP2D6_HUMAN |
CYP2D6 |
Cytochrome P450 2D6 |
9.91e-11 |
0.43
|
| ITB7_HUMAN |
ITGB7 |
Integrin beta-7 |
1.143e-10 |
0.30
|
| SC6A9_RAT |
Slc6a9 |
Sodium- and chloride-dependent glycine transporter 1 |
1.352e-10 |
0.41
|
| CY24B_HUMAN |
CYBB |
Cytochrome b-245 heavy chain |
1.967e-10 |
0.31
|
| VMAT2_RAT |
Slc18a2 |
Synaptic vesicular amine transporter |
6.945e-10 |
0.34
|
| SC6A5_RAT |
Slc6a5 |
Sodium- and chloride-dependent glycine transporter 2 |
9.008e-10 |
0.41
|
| SETD7_HUMAN |
SETD7 |
Histone-lysine N-methyltransferase SETD7 |
1.206e-09 |
0.30
|
| REV1_HUMAN |
REV1 |
DNA repair protein REV1 |
1.212e-09 |
0.37
|
| SC6A3_MOUSE |
Slc6a3 |
Sodium-dependent dopamine transporter |
1.31e-09 |
0.29
|
| CTRB1_HUMAN |
CTRB1 |
Chymotrypsinogen B |
1.828e-09 |
0.33
|
| B2CL1_MOUSE |
Bcl2l1 |
Bcl-2-like protein 1 |
2.734e-09 |
0.33
|
| PA2GA_HUMAN |
PLA2G2A |
Phospholipase A2, membrane associated |
4.536e-09 |
0.33
|
| V1AR_HUMAN |
AVPR1A |
Vasopressin V1a receptor |
5.204e-09 |
0.41
|
| BCL2_HUMAN |
BCL2 |
Apoptosis regulator Bcl-2 |
1.015e-08 |
0.36
|
| MTLR_HUMAN |
MLNR |
Motilin receptor |
1.028e-08 |
0.35
|
| ABHD6_MOUSE |
Abhd6 |
Monoacylglycerol lipase ABHD6 |
1.063e-08 |
0.39
|
| 5HT2B_HUMAN |
HTR2B |
5-hydroxytryptamine receptor 2B |
1.52e-08 |
0.43
|
| Q9JKC1_RAT |
Bche |
Carboxylic ester hydrolase |
1.833e-08 |
0.33
|
| CPT1B_RAT |
Cpt1b |
Carnitine O-palmitoyltransferase 1, muscle isoform |
1.989e-08 |
0.37
|
| CAC1G_HUMAN |
CACNA1G |
Voltage-dependent T-type calcium channel subunit alpha-1G |
2.657e-08 |
0.40
|
| ACES_HUMAN |
ACHE |
Acetylcholinesterase |
3.333e-08 |
0.33
|
| MRP1_HUMAN |
ABCC1 |
Multidrug resistance-associated protein 1 |
5.836e-08 |
0.32
|
| CHLE_HORSE |
BCHE |
Cholinesterase |
8.868e-08 |
0.33
|
| NPY2R_HUMAN |
NPY2R |
Neuropeptide Y receptor type 2 |
1.076e-07 |
0.38
|
| V2R_HUMAN |
AVPR2 |
Vasopressin V2 receptor |
1.162e-07 |
0.41
|
| GNRHR_RAT |
Gnrhr |
Gonadotropin-releasing hormone receptor |
1.668e-07 |
0.32
|
| RET4_HUMAN |
RBP4 |
Retinol-binding protein 4 |
2.004e-07 |
0.30
|
| IP3KB_HUMAN |
ITPKB |
Inositol-trisphosphate 3-kinase B |
2.595e-07 |
0.32
|
| UR2R_HUMAN |
UTS2R |
Urotensin-2 receptor |
3.764e-07 |
0.44
|
| SC6A4_HUMAN |
SLC6A4 |
Sodium-dependent serotonin transporter |
4.021e-07 |
0.50
|
| CAH3_BOVIN |
CA3 |
Carbonic anhydrase 3 |
4.707e-07 |
0.30
|
| MGLL_MOUSE |
Mgll |
Monoglyceride lipase |
6.237e-07 |
0.39
|
| CA2D1_RAT |
Cacna2d1 |
Voltage-dependent calcium channel subunit alpha-2/delta-1 |
6.359e-07 |
0.36
|
| TS1R1_HUMAN |
TAS1R1 |
Taste receptor type 1 member 1 |
7.516e-07 |
0.33
|
| EBP_HUMAN |
EBP |
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase |
8.329e-07 |
0.31
|
| HRH1_HUMAN |
HRH1 |
Histamine H1 receptor |
8.482e-07 |
0.76
|
| 5HT5A_HUMAN |
HTR5A |
5-hydroxytryptamine receptor 5A |
8.505e-07 |
0.45
|
| HS90B_HUMAN |
HSP90AB1 |
Heat shock protein HSP 90-beta |
1.225e-06 |
0.40
|
| ALR_HUMAN |
GFER |
FAD-linked sulfhydryl oxidase ALR |
1.583e-06 |
0.46
|
| LPAR2_HUMAN |
LPAR2 |
Lysophosphatidic acid receptor 2 |
2.824e-06 |
0.39
|
| 5HT3A_HUMAN |
HTR3A |
5-hydroxytryptamine receptor 3A |
3.238e-06 |
0.42
|
| CACB1_RAT |
Cacnb1 |
Voltage-dependent L-type calcium channel subunit beta-1 |
3.281e-06 |
0.36
|
| OX1R_HUMAN |
HCRTR1 |
Orexin receptor type 1 |
3.796e-06 |
0.47
|
| SYMC_HUMAN |
MARS1 |
Methionine--tRNA ligase, cytoplasmic |
5.132e-06 |
0.33
|
| OX2R_HUMAN |
HCRTR2 |
Orexin receptor type 2 |
6.376e-06 |
0.47
|
| NCOA3_HUMAN |
NCOA3 |
Nuclear receptor coactivator 3 |
7.977e-06 |
0.32
|
| PA2G5_HUMAN |
PLA2G5 |
Calcium-dependent phospholipase A2 |
9.055e-06 |
0.31
|
| AGTR2_HUMAN |
AGTR2 |
Type-2 angiotensin II receptor |
9.495e-06 |
0.45
|